CRBN and AL amyloidosis: CC-92480 is another oral CRBN E3 ligase modulator currently under clinical investigation in patients with newly diagnosed and/or refractory/relapsed multiple myeloma (NCT03374085, NCT05552976, NCT05519085, NCT03989414, NCT05372354).